DGAP-News: Medios AG / Key word(s): Takeover 
Medios AG: Planned takeover of Cranach Pharma GmbH approved by Cartel Office 
 
2020-12-21 / 12:19 
The issuer is solely responsible for the content of this announcement. 
 
*Press Release* 
 
*Medios AG: Planned takeover of Cranach Pharma GmbH approved by Cartel 
Office* 
 
Berlin, 21 December 2020 - The German Federal Cartel Office has approved 
Medios AG's intended takeover of the specialized pharmaceutical wholesaler 
Cranach Pharma GmbH, Hamburg, on 21 December 2020. 
 
Medios AG had concluded a purchase agreement with BMSH GmbH for the takeover 
of Cranach Pharma GmbH on 26 November 2020. The merger will create the 
largest Specialty Pharma provider in Germany with group sales of well over 
&euro1bn in the 2021 financial year. 
 
The closing of the transaction is planned for the first quarter of 2021. 
 
=------------------ 
 
*About Medios AG* 
Medios AG is one of the leading Specialty Pharma companies in Germany. As a 
specialist for the provision of Specialty Pharma drugs to patients, 
GMP-certified provider of patient-specific therapies and innovative 
analytical methods, Medios covers substantial elements of the supply chain 
in this field and follows the highest international quality standards. 
Usually, Specialty Pharma drugs are high-priced medicines for rare and/or 
chronic diseases. Patient-specific therapies are, for example, infusions 
that are compiled and produced on the basis of individual diseases and 
parameters like body weight and surface. In the field of drug safety, NIR 
spectroscopic analysis methods (NIR: Near infrared) are used to distinguish 
marketable finished drugs from drug counterfeits. It is Medios' aim to 
provide integrated solutions along the value chain to partners and clients, 
thereby ensuring an optimal pharmaceutical care for patients. 
 
Medios AG is Germany's first publicly listed Specialty Pharma company. The 
shares (ISIN: DE000A1MMCC8, DE000A288821) are listed in the Regulated Market 
of the Frankfurt Stock Exchange (Prime Standard). The Company is listed in 
the SDAX selection index. 
 
*Contact* 
Claudia Nickolaus 
Head of Investor & Public Relations 
Medios AG 
Heidestraße 9 | 10557 Berlin | Germany 
P +49 30 232 566 800 
c.nickolaus@medios.ag 
www.medios.ag 
 
Nikolaus Hammerschmidt 
Senior Consultant Investor & Public Relations 
Kirchhoff Consult AG 
Borselstraße 20 | 22765 Hamburg | Germany 
P +49 40 609 186 18 
nikolaus.hammerschmidt@kirchhoff.de 
www.kirchhoff.de 
 
*Disclaimer* 
This notification contains forward-looking statements that are subject to 
certain risks and uncertainties. Future results may significantly deviate 
from currently expected results, specifically due to various risk factors 
and uncertainties such as changes in business, economic, and competitive 
circumstances, exchange rate fluctuations, uncertainties about legal 
disputes or investigations, and the availability of financial resources. 
Medios AG assumes no responsibility whatsoever for updating the 
forward-looking statements contained in this notification. 
 
2020-12-21 Dissemination of a Corporate News, transmitted by DGAP - a 
service of EQS Group AG. 
The issuer is solely responsible for the content of this announcement. 
 
The DGAP Distribution Services include Regulatory Announcements, 
Financial/Corporate News and Press Releases. 
Archive at www.dgap.de 
Language:    English 
Company:     Medios AG 
             Heidestraße 9 
             10557 Berlin 
             Germany 
Phone:       +49 30 232 566 - 800 
Fax:         +49 30 232 566 - 801 
E-mail:      ir@medios.ag 
Internet:    www.medios.ag 
ISIN:        DE000A1MMCC8 
WKN:         A1MMCC 
Indices:     SDAX 
Listed:      Regulated Market in Frankfurt (Prime Standard); Regulated 
             Unofficial Market in Dusseldorf 
EQS News ID: 1156353 
 
End of News DGAP News Service 
 
1156353 2020-12-21

(END) Dow Jones Newswires

December 21, 2020 06:19 ET (11:19 GMT)